Clinical Trials Directory

Trials / Completed

CompletedNCT04957082

Culturally-Targeted COVID-19 Communication and SARS-CoV-2 Antibody Testing Evaluation and Uptake

Culturally-targeted Communication to Promote SARS-CoV-2 Antibody Testing in Saliva: Enabling Evaluation of Inflammatory Pathways in COVID-19 Racial Disparities

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
666 (actual)
Sponsor
Michigan State University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This disparities-focused study seeks to evaluate communication strategies for better encouraging understanding and uptake of salivary SARS-CoV-2 antibody testing among African Americans residing in Flint, Michigan. This iteration will consider individuals recruited from the Flint Registry and assess willingness to participate in a drive-up saliva sample collection taking place at a central location in Flint, Michigan.

Detailed description

African Americans develop and die from SARS-CoV-2 infection more than any other racial group in the United States, including in majority African American cities such as Flint, Michigan. Addressing these disparities may be aided by SARS-CoV-2 antibody testing. However, African Americans may be reluctant to partake in conventional antibody testing programs due to medical mistrust and experiences with racism. This study seeks to evaluate communication strategies for better encouraging understanding and uptake of salivary SARS-CoV-2 antibody testing. The central hypothesis is that African-Americans will be more receptive to antibody testing when benefits and limitations are communicated in a culturally effective manner. Our clinical trial aims are to 1) develop and compare effects of a general versus culturally-targeted video about antibody testing on African American and White Flint residents' antibody testing attitudes and uptake; 2) identify and compare effects of a general versus culturally-targeted video on activation of medical mistrust and racism-related cognition among African Americans when considering antibody testing. In collaboration with clinical and community partners, we have prepared and will evaluate general and culturally-targeted video tutorials about SARS-CoV-2 antibody testing. These brief videos will be distributed to the Flint community through the Flint Registry - a highly visible local health resource exchange. We will furnish an opportunity to engage salivary antibody screening and measure willingness to participate. In this study iteration, we will consider willingness to participate in a drive-up saliva sample collection that is taking place at a central location in Flint, Michigan.

Conditions

Interventions

TypeNameDescription
BEHAVIORALCulturally Targeted SARS-CoV-2 CommunicationSARS-CoV-2 video tutorial includes a one minute video based messaging adjunct meant to enact a culturally targeted framing of health information presented to African Americans.
BEHAVIORALGeneral SARS-CoV-2 CommunicationSARS-CoV-2 video tutorial is for general consumption and does not include culturally targeted information

Timeline

Start date
2021-08-04
Primary completion
2022-12-19
Completion
2022-12-19
First posted
2021-07-12
Last updated
2024-06-28
Results posted
2024-06-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04957082. Inclusion in this directory is not an endorsement.